Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Nxera Pharma UK | Heptares Therapeutics

Biotech & Life Sciences · Great Abington, United Kingdom · Founded 2007 Colt

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$100–500M
Latest valuation · 2026
Unlock exact value
Revenue
$50–100M
Latest reported FY
Unlock exact value

Investors

7 investors on Nxera Pharma UK | Heptares Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage
Series A 2 investors entered at this stage

See Nxera Pharma UK | Heptares Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.